HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alexander Kreuter Selected Research

Mucinoses

6/2012Complete clearance of reticular erythematous mucinosis with quinacrine monotherapy.
6/2011Clinical features and efficacy of antimalarial treatment for reticular erythematous mucinosis: a case series of 11 patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alexander Kreuter Research Topics

Disease

23Systemic Scleroderma (Systemic Sclerosis)
01/2021 - 05/2004
21Neoplasms (Cancer)
11/2021 - 06/2004
13Melanoma (Melanoma, Malignant)
04/2022 - 05/2009
10Localized Scleroderma (Morphea)
02/2016 - 02/2002
8Cutaneous Lupus Erythematosus
04/2022 - 09/2004
8Fibrosis (Cirrhosis)
01/2021 - 11/2009
7Lichen Sclerosus et Atrophicus (Lichen Sclerosus)
07/2013 - 02/2002
7Skin Diseases (Skin Disease)
08/2008 - 02/2002
6Nephrogenic Fibrosing Dermopathy
01/2012 - 11/2008
4Skin Neoplasms (Skin Cancer)
04/2022 - 05/2021
4Neoplasm Metastasis (Metastasis)
01/2022 - 05/2009
4Carcinoma (Carcinomatosis)
02/2021 - 07/2008
4Inflammation (Inflammations)
10/2014 - 08/2002
4Infections
04/2014 - 08/2008
4Atopic Dermatitis (Atopic Eczema)
07/2013 - 08/2002
4Psoriasis (Pustulosis Palmaris et Plantaris)
07/2012 - 04/2005
3Disease Progression
07/2021 - 11/2009
3Anus Neoplasms (Anal Cancer)
12/2020 - 04/2009
3Lymphoma (Lymphomas)
10/2020 - 01/2006
3Pain (Aches)
02/2016 - 10/2004
3Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
01/2014 - 04/2005
3Ulcer
10/2013 - 07/2008
3Dysplastic Nevus Syndrome (Dysplastic Nevus)
06/2009 - 05/2009
3Erythema
03/2009 - 10/2004
2Brain Neoplasms (Brain Tumor)
01/2022 - 01/2020
2Pyoderma Gangrenosum
01/2020 - 03/2005
2Livedoid Vasculopathy
02/2016 - 10/2004
2Carcinogenesis
05/2015 - 09/2004
2Connective Tissue Diseases (Connective Tissue Disease)
04/2015 - 09/2004
2Dermatitis
11/2014 - 07/2013
2Pruritus (Itching)
06/2014 - 09/2006
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
07/2013 - 01/2013
2T-Cell Lymphoma (Lymphoma, T Cell)
05/2013 - 12/2005
2Leg Ulcer
11/2012 - 01/2011
2Mucinoses
06/2012 - 06/2011
2Calciphylaxis
12/2011 - 03/2009
2Nausea
06/2011 - 03/2009
2Keloid
05/2011 - 02/2007
2HIV Infections (HIV Infection)
04/2011 - 12/2006
2Nevus (Nevi)
06/2009 - 05/2009
2Kaposi Sarcoma (Kaposi's Sarcoma)
06/2008 - 01/2005
2Granuloma Annulare
09/2006 - 03/2002
2Scleromyxedema (Lichen Myxedematosus)
10/2005 - 03/2005
1Basal Cell Carcinoma (Rodent Ulcer)
04/2022
1Alopecia (Baldness)
04/2022
1COVID-19
01/2022
1Herpes Zoster
01/2022

Drug/Important Bio-Agent (IBA)

10Proteins (Proteins, Gene)FDA Link
01/2021 - 03/2005
9DNA (Deoxyribonucleic Acid)IBA
01/2019 - 02/2006
8Messenger RNA (mRNA)IBA
11/2012 - 10/2006
7Adrenal Cortex Hormones (Corticosteroids)IBA
01/2020 - 03/2002
5Biomarkers (Surrogate Marker)IBA
04/2022 - 09/2010
5Immune Checkpoint InhibitorsIBA
01/2022 - 01/2016
5CytokinesIBA
10/2017 - 09/2008
5Imiquimod (Aldara)FDA LinkGeneric
08/2008 - 06/2004
4Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2022 - 01/2018
4Bleomycin (Blenoxane)FDA LinkGeneric
01/2021 - 05/2015
4Transforming Growth Factor beta (TGF-beta)IBA
01/2018 - 10/2006
4Contrast MediaIBA
01/2012 - 10/2009
4GadoliniumIBA
01/2012 - 10/2009
3Indicators and Reagents (Reagents)IBA
07/2021 - 05/2011
3Papillomavirus Vaccines (HPV Vaccines)IBA
02/2021 - 01/2011
3CollagenIBA
05/2015 - 05/2004
3Interleukin-6 (Interleukin 6)IBA
12/2012 - 09/2008
3Antimicrobial PeptidesIBA
11/2012 - 01/2008
3pimecrolimus (Elidel)FDA Link
09/2006 - 09/2004
3Intravenous Immunoglobulins (IVIG)FDA Link
01/2005 - 10/2004
2pembrolizumabIBA
04/2022 - 01/2022
2IpilimumabIBA
01/2022 - 01/2016
2NivolumabIBA
01/2022 - 09/2019
2Type I DNA Topoisomerases (Topoisomerase I)IBA
01/2021 - 01/2018
2AntibodiesIBA
01/2020 - 03/2013
2AutoantibodiesIBA
04/2015 - 03/2013
2InterferonsIBA
10/2014 - 01/2006
2Anti-Bacterial Agents (Antibiotics)IBA
10/2013 - 03/2009
2Interleukin-2 (IL2)IBA
07/2013 - 09/2008
2Interleukin-10 (Interleukin 10)IBA
11/2012 - 09/2008
2Adenosine Monophosphate (AMP)IBA
11/2012 - 07/2011
2Interleukin-8 (Interleukin 8)IBA
11/2012 - 09/2008
2FumaratesIBA
07/2012 - 03/2002
2Antimalarials (Antimalarial Agents)IBA
06/2011 - 03/2009
2Methotrexate (Mexate)FDA LinkGeneric
11/2009 - 07/2005
2DecorinIBA
07/2009 - 06/2007
2ParaffinIBA
05/2009 - 05/2009
2liposomal doxorubicin (Doxil)FDA Link
06/2008 - 01/2005
2Bexarotene (LGD1069)FDA Link
01/2006 - 12/2005
2Ficusin (Psoralen)IBA
04/2005 - 03/2002
1HhAntag691IBA
04/2022
1baricitinibIBA
04/2022

Therapy/Procedure

34Therapeutics
04/2022 - 02/2002
18Phototherapy (Light Therapy)
06/2014 - 02/2002
4Chemoradiotherapy
12/2020 - 04/2009
4Renal Dialysis (Hemodialysis)
01/2012 - 03/2009
4Photopheresis
11/2009 - 04/2005
3Radiotherapy
01/2022 - 04/2015
2Immunotherapy
01/2022 - 01/2016
2Transplantation
01/2014 - 01/2011
2Stem Cell Transplantation
01/2014 - 05/2013
2Highly Active Antiretroviral Therapy (HAART)
04/2009 - 12/2006
1Medical Day Care (Partial Hospitalization)
01/2022